A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Two recent studies—one that successfully grew human hair in a dish and another that reawakened dormant hair follicles—could lead to new hair restoration therapies for women and men.
The Columbia Stem Cell Initiative, which provides support to more than 50 laboratories across the university engaged in stem cell research, moved this spring into new facilities.
Four physician-scientists at the Vagelos College of Physicians and Surgeons have been named 2019 Louis V. Gerstner Jr. Scholars, and a fifth has been named a 2019 Louis V. Gerstner Jr. Merit Awardee.
Scientists at Columbia have developed a gene-editing tool—using jumping genes—that inserts any DNA sequence into the genome without cutting, fixing a major shortcoming of existing CRISPR technology.
A new study suggests that providers make the same number of wrong-patient errors regardless of the number of electronic patient records they could have open at a time.
Columbia engineers and surgeons show that new salvage methods can recondition severely damaged lungs to meet transplantation criteria and could make more lungs available for patients.
A new study suggests that depression and GI trouble sometimes spring from the same source—low serotonin—and identifies a potential treatment that could ease both conditions.
Four researchers at VP&S have been named 2019 Schaefer Research Scholars and will pursue new ideas in cancer metastasis, neurodegenerative disease, and compulsive behavior.